Oxford Asset Management’s Tourmaline Bio TRML Stock Holding History

Oxford Asset Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,756	Closed	-$897K	–	740
2025 Q3	$897K	Buy	+18,756	New	+$520K	0.3%	85

Oxford Asset Management's TRML Position: Q4 2025 in Review

Oxford Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 18,756 shares — an estimated $897K sold.

Oxford Asset Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $897K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Oxford Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Oxford Asset Management sold 18,756 Tourmaline Bio shares in Q4 2025, an estimated $897K.
Oxford Asset Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Oxford Asset Management's Tourmaline Bio position peaked at $897K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.